Colorectal cancer screening: Practice guidelines

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Colorectal cancer (CRC) screening has been demonstrated to reduce both incidence and mortality of CRC. There are several different screening options, each with potential benefits and some limitations. Fecal blood tests are primarily early cancer detection tests, which have been shown to reduce CRC mortality. Structural exams of the colon (flexible sigmoidoscopy, colonoscopy and imaging) may identify cancer precursor lesions (adenomas) and early cancer. There is evidence that detection and removal of adenomas may prevent many cancers. New forms of screening using stool DNA, capsule endoscopy and serum testing for genetic mutations are still in evolution, though proof-of-principle studies have been published.

Original languageEnglish (US)
Pages (from-to)34-38
Number of pages5
JournalDigestive Diseases
Volume30
Issue numberSUPPL.2
DOIs
StatePublished - Nov 2012

Fingerprint

Early Detection of Cancer
Practice Guidelines
Colorectal Neoplasms
Adenoma
Capsule Endoscopy
Sigmoidoscopy
Neoplasms
Mortality
Genetic Testing
Hematologic Tests
Colonoscopy
Colon
Mutation
DNA
Incidence
Serum

Keywords

  • Colorectal cancer screening
  • Fecal blood tests
  • Stool DNA

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Colorectal cancer screening : Practice guidelines. / Lieberman, David.

In: Digestive Diseases, Vol. 30, No. SUPPL.2, 11.2012, p. 34-38.

Research output: Contribution to journalArticle

@article{fbaf757499744b26858ca43f041516c6,
title = "Colorectal cancer screening: Practice guidelines",
abstract = "Colorectal cancer (CRC) screening has been demonstrated to reduce both incidence and mortality of CRC. There are several different screening options, each with potential benefits and some limitations. Fecal blood tests are primarily early cancer detection tests, which have been shown to reduce CRC mortality. Structural exams of the colon (flexible sigmoidoscopy, colonoscopy and imaging) may identify cancer precursor lesions (adenomas) and early cancer. There is evidence that detection and removal of adenomas may prevent many cancers. New forms of screening using stool DNA, capsule endoscopy and serum testing for genetic mutations are still in evolution, though proof-of-principle studies have been published.",
keywords = "Colorectal cancer screening, Fecal blood tests, Stool DNA",
author = "David Lieberman",
year = "2012",
month = "11",
doi = "10.1159/000341891",
language = "English (US)",
volume = "30",
pages = "34--38",
journal = "Digestive Diseases",
issn = "0257-2753",
publisher = "S. Karger AG",
number = "SUPPL.2",

}

TY - JOUR

T1 - Colorectal cancer screening

T2 - Practice guidelines

AU - Lieberman, David

PY - 2012/11

Y1 - 2012/11

N2 - Colorectal cancer (CRC) screening has been demonstrated to reduce both incidence and mortality of CRC. There are several different screening options, each with potential benefits and some limitations. Fecal blood tests are primarily early cancer detection tests, which have been shown to reduce CRC mortality. Structural exams of the colon (flexible sigmoidoscopy, colonoscopy and imaging) may identify cancer precursor lesions (adenomas) and early cancer. There is evidence that detection and removal of adenomas may prevent many cancers. New forms of screening using stool DNA, capsule endoscopy and serum testing for genetic mutations are still in evolution, though proof-of-principle studies have been published.

AB - Colorectal cancer (CRC) screening has been demonstrated to reduce both incidence and mortality of CRC. There are several different screening options, each with potential benefits and some limitations. Fecal blood tests are primarily early cancer detection tests, which have been shown to reduce CRC mortality. Structural exams of the colon (flexible sigmoidoscopy, colonoscopy and imaging) may identify cancer precursor lesions (adenomas) and early cancer. There is evidence that detection and removal of adenomas may prevent many cancers. New forms of screening using stool DNA, capsule endoscopy and serum testing for genetic mutations are still in evolution, though proof-of-principle studies have been published.

KW - Colorectal cancer screening

KW - Fecal blood tests

KW - Stool DNA

UR - http://www.scopus.com/inward/record.url?scp=84870804351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870804351&partnerID=8YFLogxK

U2 - 10.1159/000341891

DO - 10.1159/000341891

M3 - Article

C2 - 23207930

AN - SCOPUS:84870804351

VL - 30

SP - 34

EP - 38

JO - Digestive Diseases

JF - Digestive Diseases

SN - 0257-2753

IS - SUPPL.2

ER -